Search

Author/Creator Stus, Viktor

1. 1367. Clinical Cure in Secondary Efficacy Populations in Patients With Complicated Urinary Tract Infection Treated With ZTI-01 (Fosfomycin for Injection): Findings From the ZEUS Trial. (26th November 2018)

Authors:
Kaye, Keith; Rice, Louis B; Stus, Viktor; Sagan, Olexsiy; Fedosiuk, Elena; Das, Anita; Skarinksy, David; Eckburg, Paul B; Manvelian, Kristina; Ellis-Grosse, Evelyn J
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S418
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial. (6th March 2019)

Authors:
Kaye, Keith S; Rice, Louis B; Dane, Aaron L; Stus, Viktor; Sagan, Olexiy; Fedosiuk, Elena; Das, Anita F; Skarinsky, David; Eckburg, Paul B; Ellis-Grosse, Evelyn J
Journal:
Clinical infectious diseases
Issue:
Volume 69:Number 12(2019)
Page Start:
2045
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Intravenous Fosfomycin (ZTI-01) for the Treatment of Complicated Urinary Tract Infections (cUTI) Including Acute Pyelonephritis (AP): Results from a Multi-center, Randomized, Double-Blind Phase 2/3 Study in Hospitalized Adults (ZEUS). (4th October 2017)

Authors:
Kaye, Keith S; Rice, Louis B; Dane, Aaron; Stus, Viktor; Sagan, Olexsiy; Fedosiuk, Elena; Das, Anita; Skarinsky, David; Eckburg, Paul B; Ellis-Grosse, Evelyn J
Journal:
Open forum infectious diseases
Issue:
Volume 4(2017)Supplement 1
Page Start:
S528
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial. Issue 12 (December 2020)

Authors:
Powles, Thomas; Plimack, Elizabeth R; Soulières, Denis; Waddell, Tom; Stus, Viktor; Gafanov, Rustem; Nosov, Dmitry; Pouliot, Frédéric; Melichar, Bohuslav; Vynnychenko, Ihor; Azevedo, Sergio J; Borchiellini, Delphine; McDermott, Raymond S; Bedke, Jens; Tamada, Satoshi; Yin, Lina; Chen, Mei; Molife...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 12(2020)
Page Start:
1563
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections. (10th August 2019)

Authors:
Motsch, Johann; Murta de Oliveira, Cláudia; Stus, Viktor; Köksal, Iftihar; Lyulko, Olexiy; Boucher, Helen W; Kaye, Keith S; File, Thomas M; Brown, Michelle L; Khan, Ireen; Du, Jiejun; Joeng, Hee-Koung; Tipping, Robert W; Aggrey, Angela; Young, Katherine; Kartsonis, Nicholas A; Butterton, Joan R; ...
Journal:
Clinical infectious diseases
Issue:
Volume 70:Number 9(2020)
Page Start:
1799
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗